AOA Dx
PrivateLast Round
Series A
Oct 12, 2023
Total Funding Raised
$46.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AOA Dx is a biotechnology company that develops an AI-enabled multi-omics liquid biopsy platform for the early detection of ovarian cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AOA Dx Comparables
Compare AOA Dx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PROMISS Diagnostics | 89% | |
| Mercy BioAnalytics | 86% | |
| ClearNote Health | 84% |
AOA Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 12, 2023 | ||||
| Series A | Jul 1, 2023 | ||||
| Seed | Sep 13, 2022 | ||||
| Seed | Mar 1, 2022 | ||||
| Grant | Aug 16, 2021 | ||||
Pre Seed | Jun 28, 2021 |
Key People
Founding team and executive leadership
AOA Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Pre Seed |
| Canadian Institutes of Health Research | Grant |
| TBD Angels | Pre Seed |
| Gore Range Capital | Series A |
| Pioneer Fund | Pre Seed |
| Good Growth Capital | Series A |
| AlleyCorp | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 44% MoM.
- Jan 1, 2026
Developing AKRIVIS GD™, an early-stage diagnostic for ovarian cancer.
AOA Dx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AOA Dx's valuation, stock price, and market status.
Is AOA a public or private company?
AOA is a private company.
What is the current stock price of AOA?
AOA is a private company with no public stock price. No recent secondary market data is available.
How much is AOA worth (valuation)?
Valuation information for AOA is not publicly available.
Can I buy AOA stock?
AOA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AOA's last funding round?
AOA's most recent funding round was Series A on October 12, 2023.
Who are the main investors in AOA?
Key investors in AOA include Good Growth Capital, AlleyCorp, Avestria Ventures, Joyance Partners.
Will AOA IPO soon?
No public IPO plans have been announced for AOA.
How can I track AOA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AOA's secondary market activity and sign up for updates.